Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Effects of semaglutide on patient-reported outcomes in individuals with peripheral artery disease and type 2 diabetes: Findings from the STRIDE trial
Authors:
Harald Sourij1; Andrei-Mircea Catarig2; Rajitha K3; Dainis Krievins4; Bernhard Ludvik5; Kevin Mani6; Joakim Nordanstig7; Sanjana Prabhu3; Neda Rasouli8; Subodh Verma9; Marc P Bonaca10